Sinopharm Group Co. Ltd Strategic Asset Allocation Index
Sinopharm Group Co. Ltd strategic asset allocation index. Sinopharm Group Co. Ltd (X2S) has a Strategic Asset Allocation Index of 17.4% as of June 2023. Strategic assets (PP&E of €19.66 Billion plus long-term investments of €-) total €19.66 Billion, measured against net assets of €113.11 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See X2S equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Sinopharm Group Co. Ltd (2013–2022)
Strategic asset allocation index of Sinopharm Group Co. Ltd from 2013 to 2022. This chart shows how Sinopharm Group Co. Ltd's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 17.4%, representing strategic assets of €19.66 Billion against net assets of €113.11 Billion EUR. Check Sinopharm Group Co. Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Sinopharm Group Co. Ltd Strategic Asset Allocation Index by Year (2013–2022)
Sinopharm Group Co. Ltd strategic asset allocation index by year from 2013 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Sinopharm Group Co. Ltd from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Sinopharm Group Co. Ltd.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 17.8% | €19.65 Billion | €19.65 Billion | €- | €110.07 Billion | ▼ -1.6 pp |
| 2021 | 19.5% | €19.41 Billion | €19.41 Billion | €- | €99.65 Billion | ▼ -1.5 pp |
| 2020 | 21.0% | €18.90 Billion | €18.90 Billion | €- | €89.95 Billion | ▼ -2.5 pp |
| 2019 | 23.5% | €18.06 Billion | €18.06 Billion | €- | €76.94 Billion | ▼ -3.0 pp |
| 2018 | 26.5% | €18.09 Billion | €11.03 Billion | €7.07 Billion | €68.28 Billion | ▼ -3.3 pp |
| 2017 | 29.8% | €15.29 Billion | €9.01 Billion | €6.28 Billion | €51.27 Billion | ▲ +6.1 pp |
| 2016 | 23.7% | €10.55 Billion | €6.75 Billion | €3.79 Billion | €44.53 Billion | ▲ +1.4 pp |
| 2015 | 22.3% | €9.10 Billion | €7.64 Billion | €1.46 Billion | €40.88 Billion | ▼ -0.8 pp |
| 2014 | 23.1% | €8.38 Billion | €7.10 Billion | €1.28 Billion | €36.29 Billion | ▼ -2.5 pp |
| 2013 | 25.6% | €7.32 Billion | €6.31 Billion | €1.01 Billion | €28.61 Billion | — |